# Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

> **NCT01908296** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 24 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics of Quetiapine

## Interventions

- **DRUG:** FK949E
- **DRUG:** fluvoxamine

## Key facts

- **NCT ID:** NCT01908296
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01908296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01908296, "Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01908296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*